FDA Approved: ILUMYA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ILUMYA (tildrakizumab-asmn) filed by Sun Pharmaceutical Industries, expanding or modifying its regulatory authorizat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Ilumya (tildrakizumab)

Snippet

SUPPL AP for ILUMYA (TILDRAKIZUMAB-ASMN)